BurbeloPDRiedoFXMorishimaCRawlingsSSmithDDasSStrichJRChertowDSDaveyRTCohenJI. 2020. Sensitivity in detection of antibodies to nucleocapsid and spike proteins of severe acute respiratory syndrome coronavirus 2 in patients with coronavirus disease. J Infect Dis. 222(2):206–213.
2.
HuangNPérezPKatoTMikamiYOkudaKGilmoreRCCondeCDGasmiBSteinSBeachM, et al. 2021. SARS-CoV-2 infection of the oral cavity and saliva. Nat Med [epub ahead of print 25 Mar 2021] in press. doi:10.1038/s41591-021-01296-8
3.
NOT-DE-20-022: Notice of Special Interest (NOSI): availability of urgent competitive revisions and administrative supplements for coronavirus disease 2019 (COVID-19) research within the mission of NIDCR. National Institutes of Health. 2020May5 [accessed 2021 Apr 7]. https://grants.nih.gov/grants/guide/notice-files/not-de-20-022.html.
4.
NOT-DE-20-023: Notice of Special Interest (NOSI): infrastructure access for research on coronavirus disease 2019 (COVID-19) conducted in the National Dental Practice-Based Research Network. National Institutes of Health. 2020May5 [accessed 2021 Apr 7]. https://grants.nih.gov/grants/guide/notice-files/not-de-20-023.html.
5.
NOT-OD-20-152: Notice of Special Interest (NOSI): availability of emergency competitive revisions for chemosensory testing as a COVID-19 screening tool. National Institutes of Health. 2020Aug6 [accessed 2021 Apr 9]. https://grants.nih.gov/grants/guide/notice-files/NOT-OD-20-152.html.
6.
NOT-OD-21-035: Limited competition for emergency competitive revisions for novel biosensing for screening, diagnosis and monitoring of COVID-19 from skin and the oral cavity for rapid acceleration of diagnostics radical (RADx-rad). National Institutes of Health. 2020Nov25 [accessed 2021 Apr 7]. https://grants.nih.gov/grants/guide/notice-files/NOT-OD-21-035.html.
RFA-OD-20-020: Emergency awards RADx-RAD: novel biosensing for screening, diagnosis and monitoring of COVID-19 from skin and the oral cavity (R44 clinical trial not allowed). Department of Health and Human Services, National Institutes of Health. 2020Aug6 [accessed 2021 Apr 7]. https://grants.nih.gov/grants/guide/rfa-files/RFA-OD-20-020.html.
9.
RFA-OD-20-021: Emergency awards RADx-RAD: novel biosensing for screening, diagnosis and monitoring of COVID-19 from skin and the oral cavity (fast-track STTR clinical trial not allowed). National Institutes of Health. 2020Aug6 [accessed 2021 Apr 7]. https://grants.nih.gov/grants/guide/rfa-files/RFA-OD-20-021.html.
10.
RFA-OD-20-022: Emergency awards: chemosensory testing as a COVID-19 screening tool (U01 clinical trial optional). Department of Health and Human Services, National Institutes of Health. 2020Aug6 [accessed 2021 Apr 7]. https://grants.nih.gov/grants/guide/rfa-files/rfa-od-20-022.html.
ZhangLMannMSyedZReynoldsHMTianESamaraNLZeldinDCTabakLATen HagenKG. 2021. Furin cleavage of the SARS-CoV-2 spike is modulated by O-glycosylation. bioRxiv. doi: 10.1101/2021.02.05.429982.
